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Psychiatric and psychosocial disorders among cancer patients have been reported as
a major consequence of the disease and treatment. The problems in applying a pure
psychiatric approach have determined the need for structuring more deﬁned methods,
including screening for distress and emotional symptoms and a more speciﬁc psychosocial
assessment, to warrant proper care to cancer patients with psychosocial problems. This
review examines some of themost signiﬁcant issues related to these two steps, screening
and assessment of psychosocial morbidity in cancer and palliative care. With regard to
this, the many different variables, such as the factors affecting individual vulnerability (e.g.,
life events, chronic stress and allostatic load, well-being, and health attitudes) and the
psychosocial correlates of medical disease (e.g., psychiatric disturbances, psychological
symptoms, illness behavior, and quality of life) which are possibly implicated not only
in “classical” psychiatric disorders but more broadly in psychosocial suffering. Multidi-
mensional tools [e.g., and speciﬁc psychosocially oriented interview (e.g., the Diagnostic
Criteria for Psychosomatic Research)] represent a way to screen for and assess emotional
distress, anxiety and depression, maladaptive coping, dysfunctional attachment, as well
as other signiﬁcant psychosocial dimensions secondary to cancer, such as demoralization
and health anxiety. Cross-cultural issues, such as language, ethnicity, race, and religion,
are also discussed as possible factors inﬂuencing the patients and families perception of
illness, coping mechanisms, psychological response to a cancer diagnosis.
Keywords: psychosocial dimensions, DSM5, DCPR, psycho-oncology, cancer
INTRODUCTION
Psychiatric and psychosocial disorders among cancer patients have
been reported as amajor consequence of thedisease and treatment.
Sutherland (1956) among the ﬁrst indicated that the psychol-
ogy of cancer patient is that of a person under a special and
severe form of stress, during which many fundamental under-
lying convictions, based on the life-history of the person and his
experiences (e.g., pattern of relationship with attachment ﬁgures)
are brought to the surface. He also described six clinical types
of psychological reactions commonly seen after cancer diagnosis
and treatment, namely dependency, anxiety, postoperative depres-
sion, hypochondriac response, obsessive-compulsive reactions,
and paranoid reactions.
Subsequent research, by using more speciﬁc tools and inter-
views (e.g., the Diagnostic Statistical Manual for Mental Disorders
DSM-III, III-R, and IV; the International Classiﬁcation of Dis-
orders), has conﬁrmed the importance of assessing psychosocial
responses, indicating that adjustment disorders, anxiety, and
depression may be diagnosed in between 40–50% of cancer
patients (Derogatis et al., 1983; Hardman et al., 1989; Grassi et al.,
2000; Kissane et al., 2004; Singer et al., 2013). The implications and
the impact of these disorders for the patients and the families are of
paramount importance in oncology, with studies demonstrating
the association of psychosocial morbidity with maladaptive cop-
ing, reduction of quality of life (QoL), impairment in social
relationships, risk of suicide, longer rehabilitation time, poor
adherence to treatment, and abnormal illness behavior, family
dysfunction, and possibly, shorter survival (Mitchell et al., 2011).
The problems in applying a “pure” psychiatric approach, in
conducing structured psychiatric interviews in cancer settings
(Grassi and Nanni, 2013) and in having the largest possible num-
ber of cancer patients evaluated in their psychosocial dimension,
according to the new standard of treatment (Holland et al., 2011)
have determined the need for structuring more deﬁned meth-
ods. There is today a general agreement that screening for distress
and emotional symptoms is the ﬁrst important procedure to be
implemented in clinical settings, while a more speciﬁc psychoso-
cial assessment should follow, to warrant proper care to cancer
patients with psychosocial problems (Grassi et al., 2013a). This
review examines someof themost signiﬁcant issues related to these
two steps, screening and assessment of psychosocial morbidity in
cancer and palliative care.
SCREENING FOR EMOTIONAL DISORDERS
In oncology and palliative care settings there are several
dimensions including emotional distress, anxiety and depression,
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maladaptive coping, and dysfunctional attachment that, a broad
psychosomatic approach can elicit (Grassi, 2013).
EMOTIONAL DISTRESS
The [National Comprehensive Cancer Network (NCCN), 2003];
www.nccn.org established in 1997 a multidisciplinary team, con-
sistingof health care professionals fromdifferent ﬁelds thatworked
on the ﬁrst set of clinical practice standards and guidelines for the
assessment and management of the psychosocial consequences of
cancer (Holland,1997). Thepanel developed a speciﬁc instrument,
the distress thermometer (DT), as a short screening instrument
to routinely and rapidly assess distress in cancer settings. The
word “distress” was chosen to deﬁne “a multifactorial unpleasant
emotional experience of a psychological (cognitive, behavioral, emo-
tional), social, and/or spiritual nature that may interfere with the
ability to cope effectively with cancer, its physical symptoms and its
treatment. Distress extends along a continuum, ranging from com-
mon normal feelings of vulnerability, sadness and fears to problems
that can become disabling, such as depression, anxiety, panic, social
isolation and existential and spiritual crisis [. . .].” The DT is visual
analogue tool asking the subject to rate his/her level of distress on a
0–10 scale (from No Distress to Extreme Distress) and to check for
possible problems in different areas, including physical, emotional,
spiritual, family, and practical problems. National Comprehen-
sive Cancer Network (NCCN), (2003) Distress Management panel
published the standards for psychosocial care of cancer patients,
establishing a set of quality measures for screening and algo-
rhythms for managing distress and psychiatric disorders (e.g.,
adjustment disorders, depression, suicide and suicide risk, cogni-
tive disorders) which have been regularly updated on annual basis
(Holland et al., 2013). The DT and the related list of possible prob-
lems (e.g., physical, practical, interpersonal, spiritual, emotional)
increasing the risk for distress have been usedworldwide,with data
showing that although cut-off scores varied by language, country,
and clinical setting and to sample characteristics, in the majority
of studies, a score of ≥4 maximize sensitivity and speciﬁcity rel-
ative to an established criterion (e.g., psychiatric interview, other
questionnaires) for psychosocialmorbidity (Donovan et al., 2014).
Policies about the routine use of short screening tools, such
as the DT or other visual analogue scales (e.g., Edmonton Symp-
tom Assessment Scale, ESAS), have been implemented in several
countries, as a way to rapidly identify patients reporting levels of
distress indicative of psychosocial morbidity and facilitate their
proper referral to psychosocial oncology services (Bultz and Carl-
son, 2006; Bultz et al., 2011; Holland, 2013). The implications
relative to the context and the trajectory of distress, the role of the
patients’ perspective (using screening questionnaires, practition-
ers cannot discover a patient’s thoughts or feelings beyond what
the patient already knows and chooses to disclose) and the transfer
from a diagnostic to a public health framework for screening are
part of a debate still ongoing (Bultz and Johansen, 2011; Salmon
et al., 2014).
ANXIETY AND DEPRESSION
As reported by Mitchell et al. (2011) and Mitchell and Bultz
(2014) a number of data have been accumulated regarding the
screening for depression and anxiety, with the Depression in
Cancer Consensus Group reporting diagnostic validity studies
involving at least 19 tools designed to help clinicians identify
depression in cancer settings (Mitchell et al., 2012). Two stemques-
tions derived form the Patient Health Questionnaire (PHQ-2), the
Beck Depression Inventory (BDI-II) where considered acceptable.
Other instruments have been applied in psychosocial oncology
and palliative care showing that some tools can be employed as
sensitive and speciﬁc tools in clinical settings, including the Hos-
pital Anxiety and Depression Scale (HADS; Zigmond and Snaith,
1983). However recent reviews found that the HADS is a suit-
able tool for initial screening for anxiety and depression (Luckett
et al., 2010; Mitchell et al., 2010), but it cannot be proposed as
a case-ﬁnding (diagnostic) instrument. Screening for anxiety has
less been taken into consideration (apart from the data deriving
from the HADS), although it is extremely important in cancer set-
tings. The State-Trait Anxiety Inventory (STAI), the Generalized
Anxiety Disorder scale (GAD-7), the GAD for DSM, and Fear of
Disease Progression Scale (FoP; Herschbach et al., 2005) have been
reported as tools to be applied in cancer settings, although their
acceptability is also reported to be modest.
OTHER SYMPTOMS/SYNDROMES AND CLINICAL CONDITIONS
In oncology and palliative care settings, other clinical conditions
have been the object of studies aimed at evaluating the feasibility of
screening procedures. Cognitive disorders and impairment have
been examined in cancer as possible consequences of treatment.
Data regarding brief testing (bedside cognitive testing) exist with
studies evaluating the sensitivity/speciﬁcity of well-known instru-
ments, including the Mini-Mental State Examination (MMSE),
which seems tobe less accurate thanother tools, theAddenbrooke’s
Cognitive Assessment – Revised (ACE-R), the abbreviated mental
test score (AMTS), and 6-item cognitive impairment test (6CIT;
Mitchell and Bultz, 2014).
Data have been also collected regarding the dimensions of QoL
and wellbeing. With this respect the literature regarding QoL is
extremely vast and besides the scopes of this paper. It sufﬁce
to say that several groups, such as the European Organization
for Research and Treatment of Cancer (EORTC), have developed
instruments to measure a number of areas and items related to
QoL, patient’s satisfaction with doctors and health acre profession
also in general, physical, and mental symptoms, with modules rel-
ative to the single cancer disorders and sites. The EURO-Qol-5,
the Health Survey-36 (SF36), the Rotterdam Symptom Check-List
(RSCL), the Nottingham Health Proﬁle (NHP), and many others
have been however used more for research purposes rather than
routine clinical care.
ASSESSMENT OF BIOPSYCHOSOCIAL DIMENSIONS
Once screened for possible emotional and psychosocial unmet
needs or problems, patients showing symptoms or problems
should be assessed in a more proper way to examine the structural
characteristics of their clinical condition and other psychosocial
dimensions.
COPING AND ATTACHMENT
Assessment of coping, as the pattern of thoughts, beliefs, and
behaviors in response to stressful events, is part of a diagnostic
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approach to cancer patients, since maladaptive styles among can-
cer patients are intrinsically related to psychopathology (Grassi
et al., 1993). According to the transactional theory of stress and
coping (indicating that a stressor is initially appraised and, sub-
sequently, the resources available to deal with the stressor are
examined by the individual), several measures of coping have
been developed (Mitchell and Bultz, 2014). The Mental Adjust-
ment to Cancer (MAC) scale and the shorter Mini-MAC version
have been particularly used in cancer and palliative care settings
with data showing the good property of the scale (Greer et al.,
1989; Watson and Homewood, 2008) in identifying speciﬁc styles
of coping, including denial/avoidance (i.e., deliberate effort not
to think about cancer as a way cope), ﬁghting spirit (i.e., the
tendency to see the illness as a challenge), fatalism (i.e., liv-
ing in the moment and take one day at a time), helplessness/
hopelessness (i.e., desperation and hopelessness regarding the ill-
ness and the future), and anxious preoccupation (i.e., the tendency
to be anxious and extremely preoccupied about the illness).
Attachment style is also a signiﬁcant area to be explored in
the assessment phase both in oncology and palliative care, since
the way in which the patient has experienced early relations with
caregiving ﬁgures in the past relates to her view of herself and
to the expectation she has from the health care provider (or
health care system; Grassi et al., 2014). In medically ill patients,
Maunder and Hunter (2009, 2012) have described four possible
patterns of attachment, namely secure, preoccupied, dismissing,
and fearful, which are related to illness behavior, health care rela-
tionships, and health outcomes (Hunter and Maunder, 2001). In
the setting of palliative care, Tan et al. (2005) have described the
importance of attachment processes as critically important deter-
minants of therapeutic relationships, particularly when the aims
of clinicians are to improve the QoL of patients and to address the
suffering that encompasses the physical, psychosocial, and spiri-
tual realms of individuals’ and families’ experiences with terminal
illness. In research with patients with end-stage cancer, attach-
ment anxiety, and avoidance have been found to be associatedwith
less social support and more psychological distress (Hunter et al.,
2006). A further study of patients with metastatic gastrointesti-
nal and lung cancer has found that both the Experiences in Close
Relationships scale (ECR) in its 36-item version and in a shorter
form (16 items) are valid tools to identify several dimensions of
attachment in oncology (e.g., four ﬁrst-order factors Worrying
about Relationships, Frustration about Unavailability, Discomfort
with Closeness, Turning Away from Others and two second-order
factors, Attachment Anxiety and Avoidance; Lo et al., 2009).
DEMORALIZATION, HEALTH ANXIETY, AND OTHER PSYCHOSOCIAL
DIMENSIONS
The assessment of other psychosocial dimensions among can-
cer patients has been raised by research in oncology (Grassi
et al., 2007a). The Diagnostic Criteria for Psychosomatic Research
(DCPR; Fava et al., 1995) consists of twelve clinical clusters which
explore a variety of possible psychological conditions and emo-
tional responses to medical illness. Four clusters are related
to patients’ ways of perceiving, experiencing, evaluating, and
responding to their health status (abnormal illness behavior:
disease phobia, thanatophobia, health anxiety, and illness denial);
four clusters are related to the concept of somatization (i.e.,
functional somatic symptoms secondary to psychiatric disorders,
persistent somatization, conversion symptoms, and anniversary
reaction); and four to psychological dimensions that have been
frequently and consistently found in medical patients (i.e., alex-
ithymia, typeAbehavior, irritablemood, anddemoralization; Sirri
et al., 2007). The DCPR constructs of demoralization, alexithymia,
irritable mood, and anniversary reaction were found as signiﬁcant
dimensions (not detectable by ICD and DSM nosographic sys-
tems) to be taken into account in medically ill patients (Mangelli
et al., 2005, 2006; Grassi et al., 2007b; Guidi et al., 2011; De Vries
et al., 2012; Fava et al., 2012; Porcelli et al., 2012, 2013). In oncol-
ogy settings, health anxiety (37.7%), demoralization (28.8%), and
alexithymia (26%)were themost frequentDCPR clusters reported
by cancer patients in different phases of illness (Grassi et al., 2004,
2005). Patients with DCPR syndromes reported higher levels
of sadness, more physical symptoms, poorer well-being, poorer
leisure activity, and lower support from interpersonal ties, than
women without any DCPR syndrome, with higher scores on the
assessment of worries and preoccupation related to cancer (e.g.,
the illness itself, the effects of treatment, feeling different from
others, the impact on sexual life, the future). Other dimensions
related to the concept of demoralization, as a clinical syndrome
separated from major depression, have been shown to extremely
important in oncology. Loss of meaning and hope can determine
a sense of worthlessness on one’s own life and in the future which
is the hallmark of demoralization, as a syndrome to be measured
in oncology settings (Angelino and Treisman, 2001; Kissane et al.,
2001). A number of recent studies have shown that demoraliza-
tion in cancer patients is related to due to confrontation with
existential stressors that, throughout the illness across all disease
stages, impair the sense of mastery and competence. While global
sense of meaning is an important protecting factor regarding the
development of demoralization and distress symptoms (Vehling
et al., 2011), loss of dignity also has been found to be related to
demoralization (Vehling and Mehnert, 2014).
Abnormal illness behavior (i.e., affective inhibition, disease
conviction in spite of medical reassurance, frictions in inter-
personal relationships) and somatization (i.e., the tendency to
evaluate in somatic terms bodily functions) have been also
reported by both cross-sectional (Grassi et al., 1989; Chaturvedi
et al., 1993) and prospective studies of cancer patients (Grassi and
Rosti, 1996). The importance of assessing this dimension has been
undelined by some authors (Chaturvedi et al., 2006; Grassi et al.,
2013a), who showed that somatic symptoms may magnify dis-
ability resulting from cancer, interfere with treatment adherence
and decisions, cause delay in recovery, result in poor outcome
and recurrence, and reduce overall well-being and QoL, besides
complicating the diagnosis of major depression due to the over-
lap of symptoms occurring as a result of the underlying disease,
depression, or somatoform disorder.
CROSS-CULTURAL CONSIDERATIONS
A speciﬁc topic to be discussed when speaking about screening
and assessment of psychosocial consequences of cancer regards
the importance of taking into account cross-cultural issues. In fact
in the last thirty years, attention has focused on the implications
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of cultural diversity in clinical settings, particularly for racial
and ethnic minorities for whom health disparities are related to
socioeconomic disadvantage or the difﬁculty of integrating their
cultural model into the dominant model (Kagawa-Singer et al.,
2010; Surbone, 2012). Since cancer and palliative care settings are
gradually becoming multiethnic and multicultural, the need for
clear policies of screening and assessment which take into account
the implications determined by cultural diversity, is nowadays
mandatory (Grassi and Riba, 2012).
Language, ethnicity, race, and religion, have an important
role in affecting the patients and families perception of illness,
in inﬂuencing communication and doctor–patient relationship
(e.g., disclosure of information related to diagnosis and progno-
sis, role of patient and family in decision-making). Culture may
also inﬂuence a patient’s coping mechanisms, including psycho-
logical response to a cancer diagnosis, the presence, or absence of
psychopathological disorders (e.g., phenomenology of anxiety or
depression, abnormal illness behavior, somatization), the aware-
ness and knowledge of treatment options, and their acceptance of
psychological intervention. All these phenomena should be taken
into consideration when training physicians and multidisciplinary
oncology and palliative care teams (Grassi et al., 2015).
For these reasons, instruments and tools should be translated
and adapted according to the different languages and cultures,
and accuracy and analysis of validity and reliability of these tools
should be also considered in order to be clinically useful to the
clinician.
As an example, the US-based NCCN practical guidelines for
routinely screening, assessing, and managing distress are today
one of the most signiﬁcant points of reference in psychosocial
oncology (Holland et al., 2013), but the authors may not have
anticipated the potential utility of these guidelines in other cul-
tures. The translation, adaptation, and application of the NCCN
guidelines in a number of different countries and cultures indi-
cated the need for these guidelines to take into account the speciﬁc
needs of different health care systems, and relative cultures, in
the different countries (Donovan et al., 2014). This is extremely
important since the attitudes toward the concepts of illness and
suffering, decisions about treatment, and the whole of oncology
care are framed by cultural factors that also inﬂuence the social
structure of doctor–patient relationshipwithinwhich both screen-
ing and assessment of psychosocial needs are part of. Although it
is said that research on the impact of cultural issues in oncol-
ogy is not well-developed, data have accumulated regarding the
importance of cultural variables in cancer care and the speciﬁc
role of cultural competence in providing care (Seeleman et al.,
2009). Cultural (and linguistic) competence as a set of congru-
ent behaviors, attitudes, and policies enabling effective work in
cross-cultural situations, is thus a speciﬁc role in oncology, where
competence implies having the capacity to function effectively
as an individual and an organization within the context of the
cultural beliefs, behaviors, and needs presented by patients and
their support system (Surbone, 2004).
As another example, a study of breast cancer survivors of
different backgrounds (i.e., African American, Asian American,
Latina, and Caucasian) it was shown that psychosocial concerns
related to worry about children and burdening the family, body
image, and sexual health concerns, beliefs about illness, gender
role, family obligations (e.g., self-sacriﬁce), as well as language
barriers were signiﬁcantly different among the different cultural
groups (Ashing-Giwa et al., 2004). In another study, researchers
demonstrated that immigrant Chinese breast cancer survivors
may express symptoms in culturally unique ways (e.g., hot-cold
imbalances) and may be at higher risk for distress compared
with US-born Chinese and non-Hispanic breast cancer survivors,
because of cultural norms that inﬂuence the tendency to express
one’s own needs to physicians or to challenge physicians when
one’s own needs are not met (Wang et al., 2012).
These data conﬁrm the need for cultural sensitivity and compe-
tence of cancer care providers. It is clear that the creation and the
dissemination of true patient/family-centered care favor cultural
competence. In culturally sensitive patient/family-centered care,
the clinical encounter is grounded in communicationwhereby cul-
tural cues (i.e., values and beliefs) of the patient and the clinician
are incorporated within the therapeutic relationship and mutually
shared (Kumagai andLypson,2009; Teal andStreet,2009; Surbone,
2010).
Thus, screening and assessment should be part of a spe-
ciﬁc encounter with a cancer patient and her family, and thus
culturally competent communication should be part of a more
effective patient-centered communication framework, with cul-
tural competence as a necessary component in establishing a
relationship, gathering information, assessing, and managing
patients’ problems, including psychosocial disorders.
CONCLUSION
Given the importance of psychological disorders secondary to can-
cer diagnosis and treatment, careful examination of symptoms
and psychosocial needs is mandatory in oncology and palliative
care settings. Since proper psychiatric evaluation of all patients is
impossible, guide-liens have been implemented with the aim of
facilitating procedures of screening for distress and psychosocial
symptoms/needs as a routine good clinical practice. Assessment
is considered as a second step approach for those presenting
detectable symptoms/needs. Several dimensions, besides those
emerging form a standard psychiatric interview, should be specif-
ically considered. In fact, while the main aims of a standard
psychiatric approach are to establish whether a psychiatric disor-
der or other condition requiring clinical psychiatric/psychosocial
attention is present and to collect data to support the differential
diagnosis and a comprehensive clinical formulation [American
Psychiatric Association (APA), 2006], there are also different levels
of diagnosis that should be considered as not mutually exclusive
but integrated in consultation psychiatry/psychosomaticmedicine
and, by extension psychosocial oncology: the clinical diagnosis,
which it is nosologically-oriented, allowing clinicians to com-
municate with one another about the signs and symptoms the
patient is presenting (e.g., DSM, ICD); the dynamic-interpersonal
diagnosis, which is interpersonally-oriented and includes the
psychological and social variables (or forces) involved in the pre-
sentation of the patient’s symptoms, vulnerabilities and strengths;
and the genetic diagnosis which is historically-oriented, including
early experiences and life-events (e.g., attachment early experi-
ences), coping and social support (Wise, 1986). These approaches,
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in the speciﬁc setting of cancer and palliative care, as well as
of consultation-liaison psychiatry and psychosomatic medicine
(Smith et al., 2011), are part of the process of assessment and
should consider multiple dimensions. It is in fact necessary to
understand the many different variables, such as the factors affect-
ing individual vulnerability (e.g., life events, chronic stress and
allostatic load, well-being, and health attitudes) and the psychoso-
cial correlates of medical disease (e.g., psychiatric disturbances,
psychological symptoms, illness behavior, and QoL) which are
possibly implicated not only in “classical” psychiatric disorders
but more broadly in psychosocial suffering (Fava, 1996; Fava
and Sonino, 2005). Thus, the role of screening for distress (e.g.,
DT, ESAS, and other psychometric questionnaires), associated
with more speciﬁc assessment of other psychosocial dimensions
related to cancer diagnosis and treatment (e.g., attachment, cop-
ing, DCPR) need to be considered as part of routine care in
oncology and palliative care settings (Grassi et al., 2013b).
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